Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
- PMID: 34847626
- PMCID: PMC8755472
- DOI: 10.3350/cmh.2021.0338
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Keywords: Nonalcoholic fatty liver disease; Pregnancy; Pregnancy complications.
Conflict of interest statement
Comment on
-
Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes.Clin Mol Hepatol. 2022 Jan;28(1):52-66. doi: 10.3350/cmh.2021.0205. Epub 2021 Sep 17. Clin Mol Hepatol. 2022. PMID: 34530527 Free PMC article.
References
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
-
- Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62:905–914. - PubMed
-
- Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart. 2013;99:1118–1121. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
